You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GLP-1 PET

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)

Recruiting
  • Diabetes Mellitus
  • 68Ga-NODAGA-exendin-4 PET/CT
  • Vienna, Austria
  • +1 more
Jun 16, 2022

Obesity, Hypoglycemia Post Gastric Bypass Surgery, Hyperinsulinemic Hypoglycemia Trial in Arnhem (GLP-1R PET)

Recruiting
  • Obesity
  • +2 more
  • GLP-1R PET
  • Arnhem, Netherlands
    Rijnstate hospital
Oct 27, 2022

Visualizing Beta Cells After Bariatric Surgery

Recruiting
  • Type 2 Diabetes Mellitus
  • 68Ga-exendin PET/CT
  • Arnhem, Gelderland, Netherlands
  • +1 more
Jun 16, 2022

Type 2 Diabetes Trial in Uppsala (SAR425899, [68Ga] Ga-DO3A-VS-Cys40-Tuna-2 (glucagon receptor tracer), [68Ga]

Completed
  • Type 2 Diabetes Mellitus
  • Uppsala, Sweden
    Investigational Site Number 7520001
Apr 21, 2022

Type 2 Diabetes, Obesity Trial in Turku (Roux-en-Y, GIP-infusion, GLP-1)

Completed
  • Type 2 Diabetes
  • Obesity
  • Roux-en-Y
  • +4 more
  • Turku, Finland
    Turku univercity hospital, PET center
Oct 12, 2021

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Not yet recruiting
  • Gastric Ultrasound
  • +2 more
  • Gastric Ultrasound Exam
  • (no location specified)
Aug 15, 2023

Effects of GLP-1 Agonists on Gastric Volume

Not yet recruiting
  • Diabetes
  • +3 more
  • Gastric Ultrasound
  • Charleston, South Carolina
    Medical University of South Carolina
May 10, 2023

Gastric Volume in Patients on GLP-1 Medications

Recruiting
  • Diabetes
  • None - observational
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 6, 2023

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023

GLP-1, Gut Microbiota Trial in Mexico City (sucralose, )

Recruiting
  • GLP-1
  • Gut Microbiota
  • sucralose
  • placebo
  • Mexico City, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Oct 17, 2023

Delayed Gastric Emptying, Gastroparesis Trial in Chapel Hill (gastric ultrasound)

Not yet recruiting
  • Delayed Gastric Emptying
  • Gastroparesis
  • gastric ultrasound
  • Chapel Hill, North Carolina
    University of North Carolina Medical Center
Sep 8, 2023

Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

Recruiting
  • Diabetes
  • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
  • Nanjing, China
    Nanjing First Hospital, Nanjing Medical Univesity
Aug 6, 2023

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Type II Diabetes Trial in Dijon (drug, procedure, other)

Recruiting
  • Type II Diabetes
  • GLP-1 agonists
  • +2 more
  • Dijon, France
    Chu Dijon Bourgogne
Jan 2, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)

Not yet recruiting
  • Type 2 Diabetes
  • Diabetes Mellitus, Type 2
  • (no location specified)
Feb 6, 2023

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

Completed
  • Type 2 Diabetes
  • Obesity
  • Valencia, Spain
    INCLIVA
Sep 6, 2022

Obesity Trial in Singapore (Endoscopic sleeve gastroplasty)

Not yet recruiting
  • Obesity
  • Endoscopic sleeve gastroplasty
  • Singapore, Singapore
    Sengkang General Hospital
Oct 4, 2022

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Obesity Trial in Hamburg (GLP-1 (Liraglutide), Placebo)

Terminated
  • Obesity
  • GLP-1 (Liraglutide)
  • Placebo
  • Hamburg, Germany
    University Medical Center Hamburg
Jun 29, 2022

Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis-related Diabetes
  • Minneapolis, Minnesota
    University of Minnesota
Mar 15, 2023